Role of IL-1β in endotoxin potentiation of deoxynivalenol-induced corticosterone response and leukocyte apoptosis in mice

被引:46
作者
Islam, Z
Pestka, JJ
机构
[1] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA
[2] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA
[3] Michigan State Univ, Inst Environm Toxicol, E Lansing, MI 48824 USA
关键词
lipopolysaccharide; immunotoxicology; apoptosis; deoxynivalenol; vomitoxin; trichothecene; mycotoxin; thymus; Peyer's patch; bone marrow; IL-1; beta; corticosterone;
D O I
10.1093/toxsci/kfg119
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Endotoxin (lipopolysaccharide, LPS) and the trichothecenes are microbial toxins that are frequently encountered in food and the environment. Coexposure to LPS and the trichothecene deoxynivalenol (DON, vomitoxin) induces corticosterone-dependent apoptosis in thymus, Peyer's patches, and bone marrow in mice. The purpose of this study was to test the hypothesis that interleukin-1beta (IL-1beta) plays a central role in corticosterone induction and subsequent leukocyte apoptosis in this model. Coexposure to LPS (0.1 mg/kg, ip) plus DON (12.5 mg/kg, po) was found to significantly upregulate splenic IL-1beta mRNA and IL-1beta protein expression in B6C3F1 mice, as compared to treatments with vehicle or either of the toxins alone. B6.129S7-IL1r1(tm1Imx) mice, which are functionally deficient for the IL-1 receptor 1, produced significantly less corticosterone upon coexposure to LPS plus DON than did corresponding wild-type (WT) C57BL/6J mice. Consistent with these findings, IL-1 receptor 1-deficient mice were recalcitrant to apoptosis induction in leukocytes as determined by assessment of DNA fragmentation assay and flow cytometry. Furthermore, intraperitoneal injection of IL-1 receptor antagonist (100 mug/mouse, twice at 3 h intervals) in B6C3F1 mice significantly inhibited LPS plus DON-induced increases in plasma corticosterone, as well as apoptosis in thymus, Peyer's patches, and bone marrow. To confirm IL-1beta's capacity to induce apoptosis, B6C3F1 mice were injected with the cytokine (500 ng/mouse, ip) three times at 2 h intervals, and then corticosterone and apoptosis were monitored. Plasma corticosterone levels and thymus and Peyer's patch apoptosis in IL-1beta-injected mice were significantly higher at 12 h than in control mice. Plasma adrenocorticotropic hormone (ACTH) levels in LPS plus DON-treated B6C3F1 mice did not correlate with the induction of plasma corticosterone or leukocyte apoptosis. Taken together, the results indicate that IL-1beta is an important mediator of LPS plus DON-induced corticosterone and subsequent leukocyte apoptosis and, furthermore, this cytokine possibly acts through an ACTH-independent mechanism.
引用
收藏
页码:93 / 102
页数:10
相关论文
共 56 条
[1]   Physiologic role of interleukin-1 receptor antagonist [J].
Arend, WP ;
Gabay, C .
ARTHRITIS RESEARCH, 2000, 2 (04) :245-248
[2]   INVITRO EFFECT OF DIACETOXYSCIRPENOL AND DEOXYNIVALENOL ON MICROBICIDAL ACTIVITY OF MURINE PERITONEAL-MACROPHAGES [J].
AYRAL, AM ;
DUBECH, N ;
LEBARS, J ;
ESCOULA, L .
MYCOPATHOLOGIA, 1992, 120 (02) :121-127
[3]   Immunomodulation by fungal toxins [J].
Bondy, GS ;
Pestka, JJ .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2000, 3 (02) :109-143
[4]   Effects of repeated injections of interleukin 1β or lipopolysaccharide on the HPA axis in the newborn rat [J].
Bumiller, A ;
Götz, F ;
Rohde, W ;
Dörner, G .
CYTOKINE, 1999, 11 (03) :225-230
[5]   Interleukin-1β induces apoptosis in GL15 glioblastoma-derived human cell line [J].
Castigli, E ;
Arcuri, C ;
Giovagnoli, L ;
Luciani, R ;
Giovagnoli, L ;
Secca, T ;
Gianfranceschi, GL ;
Bocchini, V .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2000, 279 (06) :C2043-C2049
[6]   Effects of the IL-1 receptor antagonist on the IL-1-and endotoxin-induced activation of the HPA axis and cerebral biogenic amines in mice [J].
Dunn, AJ .
NEUROIMMUNOMODULATION, 2000, 7 (01) :36-45
[7]   Interleukin (IL)-1β-mediated apoptosis of human astrocytes [J].
Ehrlich, LC ;
Peterson, PK ;
Hu, SX .
NEUROREPORT, 1999, 10 (09) :1849-1852
[8]   Lessons from interleukin-deficient mice: the interleukin-1 system [J].
Fantuzzi, G .
ACTA PHYSIOLOGICA SCANDINAVICA, 2001, 173 (01) :5-9
[9]  
Glaccum MB, 1997, J IMMUNOL, V159, P3364
[10]   PHARMACOKINETICS, SAFETY AND IMMUNOMODULATORY EFFECTS OF HUMAN RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST IN HEALTHY HUMANS [J].
GRANOWTIZ, EV ;
PORAT, R ;
MIER, JW ;
PRIBBLE, JP ;
STILES, DM ;
BLOEDOW, DC ;
CATALANO, MA ;
WOLFF, SM ;
DINARELLO, CA .
CYTOKINE, 1992, 4 (05) :353-360